Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoyin Bai

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Journal of Translational Medicine|January 11, 2025
Possible linking and treatment between Parkinson's disease and inflammatory bowel disease: a study of Mendelian randomization based on gut-brain axisBeiming Wang, Xiaoyin Bai, Yingmai Yang, et al.
Intestinal Research|July 15, 2024
Perianal fistulizing lesions of Crohn's disease are associated with long-term behavior and its transition: a Chinese cohort studyWei Zhan, Xiaoyin Bai, Hong Yang, et al.
BMJ Open|August 23, 2019
Educational virtual reality videos in improving bowel preparation quality and satisfaction of outpatients undergoing colonoscopy: protocol of a randomised controlled trialYi Zhao, Feng Xie, Xiaoyin Bai, et al.
Clinical and Translational Science|November 5, 2022
ST2 and CSF-1 as potential druggable targets of inflammatory bowel diseases: Results from two-sample Mendelian randomization studyJiarui Mi, Xia Wu, Xiaoyin Bai, et al.
Current Therapeutic Research, Clinical and Experimental|September 3, 2024
Renal Dysfunction in a Patient With Crohn's Disease During Ustekinumab Treatment: A Case Report and Review of the LiteratureYuge Wei, Gechong Ruan, Yan Qin, et al.
European Journal of Gastroenterology & Hepatology|February 26, 2024
Comparative effectiveness and safety of ustekinumab at different intervals of maintenance phase in inflammatory bowel disease: a systematic review and meta-analysisYaqing Bai, Yinghao Sun, Qi He, et al.
Chinese Medical Journal|March 2, 2022
Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiotaXiaoyin Bai, Lingjuan Jiang, Gechong Ruan, et al.
Clinical and Translational Gastroenterology|August 7, 2025
Predictive Factors for Relapse in Autoimmune PancreatitisWenfeng Xi, Qingwei Jiang, Xiaoyin Bai, et al.
Infectious Agents and Cancer|August 29, 2025
Helicobacter pylori, peptic ulcer disease, and colorectal cancer: a prospective study with genome-wide interaction analysis and Mendelian randomizationZiqi Wan, Jiarui Mi, Xiaoyin Bai, et al.
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Journal of Translational Medicine|January 11, 2025
Possible linking and treatment between Parkinson's disease and inflammatory bowel disease: a study of Mendelian randomization based on gut-brain axisBeiming Wang, Xiaoyin Bai, Yingmai Yang, et al.
Intestinal Research|July 15, 2024
Perianal fistulizing lesions of Crohn's disease are associated with long-term behavior and its transition: a Chinese cohort studyWei Zhan, Xiaoyin Bai, Hong Yang, et al.
BMJ Open|August 23, 2019
Educational virtual reality videos in improving bowel preparation quality and satisfaction of outpatients undergoing colonoscopy: protocol of a randomised controlled trialYi Zhao, Feng Xie, Xiaoyin Bai, et al.
Clinical and Translational Science|November 5, 2022
ST2 and CSF-1 as potential druggable targets of inflammatory bowel diseases: Results from two-sample Mendelian randomization studyJiarui Mi, Xia Wu, Xiaoyin Bai, et al.
Current Therapeutic Research, Clinical and Experimental|September 3, 2024
Renal Dysfunction in a Patient With Crohn's Disease During Ustekinumab Treatment: A Case Report and Review of the LiteratureYuge Wei, Gechong Ruan, Yan Qin, et al.
European Journal of Gastroenterology & Hepatology|February 26, 2024
Comparative effectiveness and safety of ustekinumab at different intervals of maintenance phase in inflammatory bowel disease: a systematic review and meta-analysisYaqing Bai, Yinghao Sun, Qi He, et al.
Chinese Medical Journal|March 2, 2022
Helicobacter pylori may participate in the development of inflammatory bowel disease by modulating the intestinal microbiotaXiaoyin Bai, Lingjuan Jiang, Gechong Ruan, et al.
Clinical and Translational Gastroenterology|August 7, 2025
Predictive Factors for Relapse in Autoimmune PancreatitisWenfeng Xi, Qingwei Jiang, Xiaoyin Bai, et al.
Infectious Agents and Cancer|August 29, 2025
Helicobacter pylori, peptic ulcer disease, and colorectal cancer: a prospective study with genome-wide interaction analysis and Mendelian randomizationZiqi Wan, Jiarui Mi, Xiaoyin Bai, et al.
Drug Discovery Today|October 25, 2025
Therapeutic value and regulatory characteristics of breakthrough therapy drugs in the USA and China (2021-2023): a retrospective cohort studyXiangyun Mao, Haoyu Yin, Xiaoyin Bai, et al.
Pageof 8